Company Filing History:
2 out of 15,471 
1 out of 44 
1 out of 893 
Years Active: 2007-2014
Title: Innovations and Contributions of Theo N Kirkland, III
Introduction
Theo N Kirkland, III is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of medical science, particularly in the development of compositions and methods for treating infectious diseases. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing healthcare solutions.
Latest Patents
Theo N Kirkland, III holds 2 patents. His latest patents include compositions and methods using MD-2 mutants and chimeric proteins. This invention provides targeted bacteriostatic and antibacterial agents for the treatment of sepsis caused by infectious diseases, such as bacterial and fungal diseases. One aspect of the invention focuses on decreasing the levels of LPS in the circulation of individuals, particularly human patients suffering from sepsis, including those experiencing gram-negative septic shock. The invention also encompasses chimeric proteins that comprise the MD-2 polypeptide and an opsonizing agent, such as antibody Fc domains. Furthermore, it provides pharmaceutical compositions that include these chimeric polypeptides and methods for their use in ameliorating or preventing sepsis.
Career Highlights
Throughout his career, Theo has worked with prestigious institutions, including the University of California and the Medical College of Ohio. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Theo has collaborated with notable colleagues, including Sunganya Viriyakosol and Garry T Cole. These partnerships have further enriched his research and innovation efforts.
Conclusion
Theo N Kirkland, III is a prominent inventor whose work in medical science has led to significant advancements in the treatment of infectious diseases. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.